Kellia Chiu

840 total citations
19 papers, 491 citations indexed

About

Kellia Chiu is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Epidemiology. According to data from OpenAlex, Kellia Chiu has authored 19 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in General Health Professions and 5 papers in Epidemiology. Recurrent topics in Kellia Chiu's work include Opioid Use Disorder Treatment (8 papers), Health Policy Implementation Science (4 papers) and Primary Care and Health Outcomes (4 papers). Kellia Chiu is often cited by papers focused on Opioid Use Disorder Treatment (8 papers), Health Policy Implementation Science (4 papers) and Primary Care and Health Outcomes (4 papers). Kellia Chiu collaborates with scholars based in Australia, Canada and United States. Kellia Chiu's co-authors include Lisa Bero, Quinn Grundy, Andrea Continella, Lisa Parker, Ralph Holz, Fabian Held, Magdalena Wilczynska, Theresa HM Moore, Matthew Parry and Ella Flemyng and has published in prestigious journals such as Cochrane Database of Systematic Reviews, PLoS Biology and BMJ.

In The Last Decade

Kellia Chiu

17 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kellia Chiu Australia 7 139 128 116 109 88 19 491
Lisa Parker Australia 13 153 1.1× 132 1.0× 34 0.3× 119 1.1× 91 1.0× 29 551
Andreas Reis Switzerland 13 161 1.2× 25 0.2× 81 0.7× 77 0.7× 217 2.5× 39 637
Arash Shaban‐Nejad United States 15 137 1.0× 75 0.6× 5 0.0× 145 1.3× 70 0.8× 91 859
Aravind Sesagiri Raamkumar Singapore 8 30 0.2× 67 0.5× 30 0.3× 124 1.1× 7 0.1× 27 360
Lauren Sinnenberg United States 10 161 1.2× 30 0.2× 6 0.1× 235 2.2× 108 1.2× 13 801
Jeffrey T. Huber United States 12 249 1.8× 59 0.5× 26 0.2× 67 0.6× 62 0.7× 51 493
Christina Mancheno United States 6 146 1.1× 31 0.2× 5 0.0× 231 2.1× 64 0.7× 10 608
Gary Schwitzer United States 14 135 1.0× 7 0.1× 54 0.5× 213 2.0× 88 1.0× 21 549
Dehua Hu China 11 43 0.3× 19 0.1× 21 0.2× 47 0.4× 25 0.3× 35 282
Marcelo D’Agostino United States 8 615 4.4× 95 0.7× 6 0.1× 83 0.8× 186 2.1× 35 892

Countries citing papers authored by Kellia Chiu

Since Specialization
Citations

This map shows the geographic impact of Kellia Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellia Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellia Chiu more than expected).

Fields of papers citing papers by Kellia Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellia Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellia Chiu. The network helps show where Kellia Chiu may publish in the future.

Co-authorship network of co-authors of Kellia Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Kellia Chiu. A scholar is included among the top collaborators of Kellia Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellia Chiu. Kellia Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chiu, Kellia, et al.. (2025). Opioid deprescribing: rethinking policies to facilitate better patient outcomes. Pain Management. 15(7). 413–423.
2.
Chiu, Kellia, et al.. (2024). Methadone Prescribing Regulation for Opioid Use Disorder in Canada: Evidence for an East–West Policy Divide. Healthcare policy. 19(3). 49–61. 2 indexed citations
3.
Sud, Abhimanyu, et al.. (2024). Federal opioid agonist therapy policy: interrupted time series analysis of the impact of the methadone exemption removal across eight provinces in Canada. BMC Health Services Research. 24(1). 893–893. 1 indexed citations
4.
Chiu, Kellia & Abhimanyu Sud. (2024). Reframing conceptualizations of primary care involvement in opioid use disorder treatment. BMC Primary Care. 25(1). 356–356. 2 indexed citations
5.
Chiu, Kellia, et al.. (2024). An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions. Health Policy. 141. 104993–104993. 4 indexed citations
6.
Chiu, Kellia, et al.. (2023). The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment. Applied Health Economics and Health Policy. 21(3). 501–510. 2 indexed citations
7.
Sud, Abhimanyu, Kellia Chiu, Joseph Friedman, & Julie Dupouy. (2023). Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States. International Journal of Drug Policy. 120. 104161–104161. 4 indexed citations
8.
Chiu, Kellia, et al.. (2023). How policy problems and solutions travel in the scientific literature: An international scientometric analysis of the French Model of opioid use disorder care. Journal of Evaluation in Clinical Practice. 29(4). 576–590. 1 indexed citations
9.
Mintzes, Barbara, et al.. (2022). Australian Clinical Trial Authors’ Declarations of Industry Ties. Journal of General Internal Medicine. 37(12). 3196–3198. 2 indexed citations
10.
Chiu, Kellia, Anne Marie Thow, & Lisa Bero. (2022). The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. Research in Social and Administrative Pharmacy. 18(10). 3782–3791.
11.
Chiu, Kellia, Anne Marie Thow, & Lisa Bero. (2022). “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice. Research in Social and Administrative Pharmacy. 18(9). 3638–3648. 6 indexed citations
12.
Chiu, Kellia, Anne Marie Thow, & Lisa Bero. (2022). A comparative analysis of the roles and use of evidence in pharmacy policy in Australia. Evidence & Policy. 1–19. 1 indexed citations
13.
Bero, Lisa, Kellia Chiu, Sally McDonald, et al.. (2021). Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. BMJ Open. 11(7). e051821–e051821. 30 indexed citations
14.
Parker, Lisa, Lisa Bero, Sally McDonald, et al.. (2020). Comparison of preprints with peer-reviewed publications on COVID-19: Discrepancies in results reporting and conclusions. OSF Preprints (OSF Preprints). 1 indexed citations
15.
Anglemyer, Andrew, Theresa HM Moore, Lisa Parker, et al.. (2020). Digital contact tracing technologies in epidemics: a rapid review. Cochrane Database of Systematic Reviews. 2020(8). CD013699–CD013699. 142 indexed citations
16.
Bero, Lisa, Kellia Chiu, & Quinn Grundy. (2019). The SSSPIN study—spin in studies of spin: meta-research analysis. BMJ. 367. l6202–l6202. 19 indexed citations
17.
Grundy, Quinn, Kellia Chiu, & Lisa Bero. (2019). Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. Journal of General Internal Medicine. 34(12). 2833–2841. 10 indexed citations
18.
Grundy, Quinn, Kellia Chiu, Fabian Held, et al.. (2019). Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. BMJ. 364. l920–l920. 101 indexed citations
19.
Chiu, Kellia, Quinn Grundy, & Lisa Bero. (2017). ‘Spin’ in published biomedical literature: A methodological systematic review. PLoS Biology. 15(9). e2002173–e2002173. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Parker Breakdown of academic impact, for papers by Andreas Reis Breakdown of academic impact, for papers by Arash Shaban‐Nejad Breakdown of academic impact, for papers by Aravind Sesagiri Raamkumar Breakdown of academic impact, for papers by Lauren Sinnenberg Breakdown of academic impact, for papers by Jeffrey T. Huber Breakdown of academic impact, for papers by Christina Mancheno Breakdown of academic impact, for papers by Gary Schwitzer Breakdown of academic impact, for papers by Dehua Hu Breakdown of academic impact, for papers by Marcelo D’Agostino
Rankless by CCL
2026